Discontinuation of Oral Anticoagulants in Atrial Fibrillation Patients: Impact of Treatment Strategy and on Patients' Health Status.

Ryo Nakamaru Nobuhiro IkemuraTakehiro KimuraYoshinori Katsumata Charles F Sherrod Hiroshi Miyama Yasuyuki ShiraishiHideaki KankiKoji NegishiIkuko UedaKeiichi FukudaSeiji TakatsukiShun Kohsaka

Published in: Journal of clinical medicine (2023)

OAC discontinuation was common among AF patients with significant stroke risk but varied depending on the chosen treatment strategy. This study also found no significant association between OAC discontinuation and patients' health status.

Keyphrases

atrial fibrillation
end stage renal disease
ejection fraction
newly diagnosed
oral anticoagulants
peritoneal dialysis
prognostic factors
heart failure
coronary artery disease
venous thromboembolism
left atrial
brain injury
direct oral anticoagulants
subarachnoid hemorrhage